C-kit+ cardiac stem cells (C-kit+ CSCs)have emerged as some of the most promising CSCs for the prevention or treatment of myocardial remodeling and cardiac dysfunction after myocardial infarction[59]. The gene discussed is KIT; the disease is myocardial infarction.